LSTA

Market-moving news on Lisata Therapeutics (NASDAQ: LSTA): filings, earnings, deals and other events, from REDFILED.

Lisata Therapeutics plans to combine with privately held Marea Therapeutics in a stock-based reverse merger.

LSTA

LISATA THERAPEUTICS (LSTA) Agrees to Reverse Merger With Marea Therapeutics

Lisata will absorb privately held Marea Therapeutics in a stock deal accompanied by a PIPE financing in Series C convertible preferred stock.

Lisata is pivoting toward antibody treatments for severe hypertriglyceridemia and acromegaly.

LSTA

LISATA (LSTA) Buys Marea Therapeutics and Raises $225 Million in Private Placement

Lisata acquires clinical-stage Marea Therapeutics in a stock-for-stock deal, pairing it with a $225 million financing that leaves legacy holders with 2.39%.